Table of Contents
The Brown University Psychopharmacology Update · 2006
DOI: 10.1002/pu.20023 ↗Abstract
Abstract CATIE Phase 2 Tolerability Study Results Show High Treatment Discontinuation Rates Landmark STAR*D Study Highlights Value of Augmentation, Switching No Pharmacokinetic Interaction Found between Lamotrigine and Olanzapine Reboxetine Versus Fluvoxamine for PTSD Reboxetine Versus Citalopram for MDD Risperidone in Children, Adolescents and Adults with MR Questions Surround Preemptive Treatment of Schizophrenia Study Examines Trends in Off‐Label Prescribing Topiramate Plus Paroxetine in Treatment‐Resistant OCD Warning: Promethazine HCl Warning: Label Changes for Paxil
EUVIMED